Back
Krystal Biotech Vs. Axsome Therapeutics Industry Stock Comparison
Sell
36
KRYS
Krystal Biotech
Last Price:
190.20
Seasonality Move:
17.47%
Buy
63
AXSM
Axsome Therapeutics
Last Price:
91.92
Seasonality Move:
48.72%
Sell
36
Krystal Biotech (KRYS)
is a Sell
Is Krystal Biotech a Buy, Sell or Hold?
- The current Krystal Biotech [KRYS] share price is $174.41. The Score for KRYS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Axsome Therapeutics (AXSM)
is a Buy
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $89.24. The Score for AXSM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AXSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KRYS Stock Price Chart
What is Krystal Biotech's stock price today?
-
The Krystal Biotech share price today is $174.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing slight buying pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $89.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.14 | Sell |
| Relative Strength Index (14 RSI): | 45.68 | Sell |
| Chaikin Money Flow: | 102037 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (173.47 - 178.57) | Sell |
| Bollinger Bands (100): | (175.61 - 198.49) | Sell |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 49.5 | Sell |
| Chaikin Money Flow: | 229654 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.83 - 91.67) | Buy |
| Bollinger Bands (100): | (81.5 - 91.5) | Buy |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 174.79 | Sell |
| 20-day SMA: | 175.69 | Sell |
| 50-day SMA: | 182.35 | Sell |
| 200-day SMA: | 170.79 | Buy |
| 8-day EMA: | 174.46 | Sell |
| 20-day EMA: | 176.13 | Sell |
| 50-day EMA: | 180.24 | Sell |
| 200-day EMA: | 168.91 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.25 | Sell |
| 20-day SMA: | 88.66 | Buy |
| 50-day SMA: | 90.1 | Sell |
| 200-day SMA: | 82.46 | Buy |
| 8-day EMA: | 89.06 | Buy |
| 20-day EMA: | 89.26 | Sell |
| 50-day EMA: | 88.76 | Buy |
| 200-day EMA: | 82.76 | Buy |
Krystal Biotech Earnings Growth & KRYS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.98 per share, and an increase next year of $3.21 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.95 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.39 per share, and an increase next year of $3.89 per share.
Krystal Biotech Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||